THC Farmaceuticals, Inc. (CBDG)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
THC Farmaceuticals, Inc. (CBDG) with AI Score 42/100 (Weak). THC Farmaceuticals, Inc. operates a small network of ATMs in Utah. The company, formerly City Media, Inc. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 15, 2026THC Farmaceuticals, Inc. (CBDG) Healthcare & Pipeline Overview
THC Farmaceuticals, Inc. (CBDG) operates a limited number of cash-dispensing ATMs in Utah, targeting small and medium-sized businesses in high-traffic areas. Formerly City Media, the company's current focus is on ATM services, distinguishing it from biotechnology peers despite its industry classification.
Investment Thesis
THC Farmaceuticals, Inc. (CBDG) presents a speculative investment opportunity due to its limited operations and OTC market listing. The company's small ATM network in Utah generates revenue from transaction fees, but its financial viability is uncertain given the limited scale. Growth catalysts depend on expanding the ATM network and increasing transaction volume. Key risks include limited capital, competition from established ATM operators, and regulatory challenges associated with the OTC market. The company's negative P/E ratio of -55.69 and a beta of -9.64 reflect its volatile financial performance and market sensitivity.
Based on FMP financials and quantitative analysis
Key Highlights
- Operates a small network of eight ATMs in Utah as of June 30, 2015.
- Formerly known as City Media, Inc., changed its name to THC Farmaceuticals, Inc. in February 2015.
- Subsidiary of Weed Growth Fund, Inc.
- Targets small and medium-sized businesses in high-traffic areas.
- P/E ratio of -55.69 indicates negative earnings.
Competitors & Peers
Strengths
- Established ATM network in Utah.
- Relationships with local businesses.
- Convenient ATM locations.
- Subsidiary of Weed Growth Fund, Inc.
Weaknesses
- Limited geographic scope.
- Small ATM network.
- Dependence on transaction fees.
- Negative P/E ratio.
Catalysts
- Ongoing: Expansion of ATM network into new locations.
- Ongoing: Strategic partnerships with local businesses.
- Upcoming: Technological upgrades to existing ATMs.
- Upcoming: Implementation of targeted marketing campaigns.
- Upcoming: Diversification of services offered through ATMs.
Risks
- Potential: Increased competition from larger ATM networks.
- Potential: Shift towards digital payment solutions.
- Potential: Regulatory changes affecting ATM operations.
- Potential: Economic downturn impacting transaction volume.
- Ongoing: Limited financial disclosure and liquidity.
Growth Opportunities
- Expansion of ATM Network: THC Farmaceuticals can grow by expanding its ATM network within Utah and potentially into neighboring states. Identifying strategic locations with high foot traffic and limited ATM access is crucial. The market for ATM services in underserved areas presents an opportunity to increase transaction volume and revenue, although this requires capital investment and operational expertise.
- Strategic Partnerships: Forming partnerships with local businesses and event organizers can increase ATM visibility and usage. Offering exclusive deals or discounts to customers who use THC Farmaceuticals' ATMs can incentivize transactions. These partnerships can create a mutually beneficial ecosystem, driving revenue for both the company and its partners.
- Technological Upgrades: Upgrading existing ATMs with advanced features such as contactless payment options and mobile wallet integration can attract a wider customer base. Investing in secure and reliable ATM technology is essential for maintaining customer trust and preventing fraud. These upgrades can enhance the user experience and increase transaction volume.
- Targeted Marketing Campaigns: Implementing targeted marketing campaigns to promote the convenience and accessibility of THC Farmaceuticals' ATMs can drive customer awareness and usage. Utilizing social media, local advertising, and in-store promotions can effectively reach the target audience. These campaigns should highlight the benefits of using ATMs for cash transactions.
- Diversification of Services: Exploring opportunities to offer additional services through its ATM network, such as bill payment and prepaid card loading, can generate new revenue streams. Partnering with service providers to offer these value-added services can enhance the attractiveness of THC Farmaceuticals' ATMs. This diversification can increase customer engagement and loyalty.
Opportunities
- Expansion into new locations.
- Strategic partnerships.
- Technological upgrades.
- Diversification of services.
Threats
- Competition from larger ATM networks.
- Increasing use of digital payment solutions.
- Regulatory changes.
- Economic downturn.
Competitive Advantages
- Limited geographic focus in Utah.
- Established relationships with local businesses.
- Convenient ATM locations in high-traffic areas.
About CBDG
Founded in 2008 and based in Scottsdale, Arizona, THC Farmaceuticals, Inc., formerly known as City Media, Inc., transitioned to its current name in February 2015. The company operates as a subsidiary of Weed Growth Fund, Inc. Its primary business involves owning and operating non-financial institution cash-dispensing automated teller machines (ATMs) at third-party owned retail and commercial locations. These ATMs are strategically placed in locations such as hotels, stores, and bowling alleys, targeting small and medium-sized businesses with high customer traffic. As of June 30, 2015, THC Farmaceuticals had a total of eight ATMs in operation along the Wasatch Front in the State of Utah. The company's operations are limited geographically and in scale, focusing on providing convenient cash access in specific locales.
What They Do
- Owns and operates cash-dispensing ATMs.
- Places ATMs in third-party retail and commercial locations.
- Targets hotels, stores, and bowling alleys.
- Focuses on small and medium-sized businesses.
- Provides cash access in high-traffic areas.
- Operates in the State of Utah.
Business Model
- Generates revenue from transaction fees charged to ATM users.
- Partners with retail and commercial locations to host ATMs.
- Maintains and services its ATM network.
Industry Context
THC Farmaceuticals, Inc. operates within the broader financial services industry, specifically in the niche market of non-bank ATM operations. The ATM market is characterized by established players and increasing competition from digital payment solutions. While the overall ATM market is mature, opportunities exist for smaller operators to serve niche markets and specific geographic areas. THC Farmaceuticals' limited scale and focus on the Utah market position it as a micro-player within this landscape, facing competition from larger ATM networks and evolving payment technologies.
Key Customers
- Retail customers needing cash access.
- Small and medium-sized businesses hosting ATMs.
- Tourists and visitors requiring cash transactions.
Financials
Chart & Info
THC Farmaceuticals, Inc. (CBDG) stock price: Price data unavailable
Latest News
No recent news available for CBDG.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CBDG.
Price Targets
Wall Street price target analysis for CBDG.
MoonshotScore
What does this score mean?
The MoonshotScore rates CBDG's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Ed Rosenthal
CEO
Information on Ed Rosenthal's background is not available in the provided data. Further research would be needed to determine his career history, education, and previous roles. Without this information, a comprehensive profile cannot be created.
Track Record: Information on Ed Rosenthal's track record is not available in the provided data. Further research would be needed to determine his key achievements, strategic decisions, and company milestones under his leadership. Without this information, a comprehensive assessment cannot be provided.
CBDG OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that THC Farmaceuticals, Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial information available and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the potential for limited liquidity and transparency.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure.
- Low trading volume and liquidity.
- Potential for price manipulation.
- Higher risk of fraud or scams.
- Limited regulatory oversight.
- Verify the company's registration and legal status.
- Review available financial statements and disclosures.
- Assess the company's business model and revenue streams.
- Research the company's management team and their track record.
- Evaluate the company's competitive landscape and market position.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor.
- Subsidiary of Weed Growth Fund, Inc.
- Operational ATM network in Utah.
- Established business since 2008.
Common Questions About CBDG
What does THC Farmaceuticals, Inc. do?
THC Farmaceuticals, Inc. operates a network of cash-dispensing ATMs in retail and commercial locations, primarily targeting small and medium-sized businesses in Utah. The company generates revenue through transaction fees charged to ATM users. Its business model focuses on providing convenient cash access in high-traffic areas, competing with larger ATM networks and evolving digital payment solutions. The company's limited scale and geographic focus present both opportunities and challenges in the competitive financial services landscape.
What do analysts say about CBDG stock?
As of 2026-03-15, there is no available analyst coverage for THC Farmaceuticals, Inc. (CBDG). The company's OTC listing and limited operations likely contribute to the lack of analyst attention. Investors should conduct their own due diligence and consider the risks associated with investing in OTC stocks. Key valuation metrics, such as P/E ratio and market capitalization, should be evaluated in the context of the company's limited financial disclosure and liquidity.
What are the main risks for CBDG?
The main risks for THC Farmaceuticals, Inc. (CBDG) include limited financial disclosure, low trading volume and liquidity, potential for price manipulation, and higher risk of fraud or scams due to its OTC listing. The company also faces competition from larger ATM networks and the increasing adoption of digital payment solutions. Regulatory changes and economic downturns could further impact the company's financial performance and viability. Investors should carefully consider these risks before investing in CBDG.
What are the key factors to evaluate for CBDG?
THC Farmaceuticals, Inc. (CBDG) currently holds an AI score of 42/100, indicating low score. Key strength: Established ATM network in Utah.. Primary risk to monitor: Potential: Increased competition from larger ATM networks.. This is not financial advice.
How frequently does CBDG data refresh on this page?
CBDG prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven CBDG's recent stock price performance?
Recent price movement in THC Farmaceuticals, Inc. (CBDG) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Established ATM network in Utah.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider CBDG overvalued or undervalued right now?
Determining whether THC Farmaceuticals, Inc. (CBDG) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying CBDG?
Before investing in THC Farmaceuticals, Inc. (CBDG), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on THC Farmaceuticals, Inc.
- OTC market carries higher risks.
- Financial data is limited.